PBU The Pension Fund of Early Childhood & Youth Educators Invests $11.53 Million in HCA Healthcare, Inc. $HCA

PBU The Pension Fund of Early Childhood & Youth Educators bought a new position in HCA Healthcare, Inc. (NYSE:HCAFree Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 24,706 shares of the company’s stock, valued at approximately $11,534,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. MJP Associates Inc. ADV increased its holdings in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its position in shares of HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares during the last quarter. Centerpoint Advisors LLC boosted its position in shares of HCA Healthcare by 11.0% during the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after buying an additional 22 shares during the last quarter. Cary Street Partners Financial LLC boosted its position in shares of HCA Healthcare by 3.9% during the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after buying an additional 22 shares during the last quarter. Finally, Plato Investment Management Ltd boosted its position in shares of HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Stock Up 2.9%

HCA stock opened at $372.29 on Friday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The stock has a market cap of $82.59 billion, a P/E ratio of 12.80, a PEG ratio of 1.15 and a beta of 1.12. The business’s 50-day moving average price is $439.51 and its 200-day moving average price is $477.20.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the previous year, the firm earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Argus dropped their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Stephens dropped their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. KeyCorp dropped their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Barclays dropped their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Finally, Wells Fargo & Company dropped their target price on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research report on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $506.14.

Get Our Latest Analysis on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.